> top > docs > PMC:7170415 > spans > 15143-16372 > annotations

PMC:7170415 / 15143-16372 JSONTXT

Annnotations TAB JSON ListView MergeView

LitCovid-PubTator

Id Subject Object Predicate Lexical cue tao:has_database_id
225 387-391 Gene denotes RdRP Gene:43740578
226 149-161 Gene denotes nucleocapsid Gene:43740575
227 65-75 Species denotes SARS–CoV-2 Tax:2697049
228 192-197 Species denotes human Tax:9606
229 346-356 Species denotes SARS–CoV-2 Tax:2697049
230 485-495 Species denotes SARS–CoV-2 Tax:2697049
231 561-574 Species denotes coronaviruses Tax:11118

LitCovid-PD-FMA-UBERON

Id Subject Object Predicate Lexical cue fma_id
T15 162-166 Body_part denotes gene http://purl.org/sig/ont/fma/fma74402
T16 206-210 Body_part denotes gene http://purl.org/sig/ont/fma/fma74402
T17 225-228 Body_part denotes RNA http://purl.org/sig/ont/fma/fma67095
T18 357-360 Body_part denotes RNA http://purl.org/sig/ont/fma/fma67095
T19 371-374 Body_part denotes RNA http://purl.org/sig/ont/fma/fma67095

LitCovid-PD-MONDO

Id Subject Object Predicate Lexical cue mondo_id
T64 65-69 Disease denotes SARS http://purl.obolibrary.org/obo/MONDO_0005091
T65 346-350 Disease denotes SARS http://purl.obolibrary.org/obo/MONDO_0005091
T66 485-489 Disease denotes SARS http://purl.obolibrary.org/obo/MONDO_0005091

LitCovid-PD-CLO

Id Subject Object Predicate Lexical cue
T142 26-29 http://purl.obolibrary.org/obo/CL_0000990 denotes CDC
T143 30-33 http://purl.obolibrary.org/obo/CLO_0051582 denotes has
T144 162-166 http://purl.obolibrary.org/obo/OGG_0000000002 denotes gene
T145 192-197 http://purl.obolibrary.org/obo/NCBITaxon_9606 denotes human
T146 206-210 http://purl.obolibrary.org/obo/OGG_0000000002 denotes gene
T147 297-309 http://purl.obolibrary.org/obo/OBI_0000245 denotes Organization
T148 410-415 http://purl.obolibrary.org/obo/OGG_0000000002 denotes genes
T149 589-590 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T150 660-663 http://purl.obolibrary.org/obo/CL_0000990 denotes CDC
T151 926-933 http://purl.obolibrary.org/obo/UBERON_0000473 denotes testing
T152 935-937 http://purl.obolibrary.org/obo/CLO_0050509 denotes 27
T153 1070-1072 http://purl.obolibrary.org/obo/CLO_0001302 denotes 34
T154 1088-1091 http://purl.obolibrary.org/obo/CLO_0051582 denotes has
T155 1138-1140 http://purl.obolibrary.org/obo/CLO_0001000 denotes 35

LitCovid-PD-CHEBI

Id Subject Object Predicate Lexical cue chebi_id
T14 111-116 Chemical denotes probe http://purl.obolibrary.org/obo/CHEBI_50406
T15 175-177 Chemical denotes N2 http://purl.obolibrary.org/obo/CHEBI_17997
T16 317-322 Chemical denotes probe http://purl.obolibrary.org/obo/CHEBI_50406

LitCovid-PD-GO-BP

Id Subject Object Predicate Lexical cue
T15 198-205 http://purl.obolibrary.org/obo/GO_0004526 denotes RNase P
T16 387-391 http://purl.obolibrary.org/obo/GO_0003968 denotes RdRP

LitCovid-sentences

Id Subject Object Predicate Lexical cue
T113 0-82 Sentence denotes In the United States, the CDC has developed the most widely used SARS–CoV-2 assay.
T114 83-255 Sentence denotes The kit contains PCR primer–probe sets for 2 regions of the viral nucleocapsid gene (N1 and N2), and for the human RNase P gene to ensure the RNA extraction was successful.
T115 256-421 Sentence denotes This assay differs from the World Health Organization primer–probe sets, which target the SARS–CoV-2 RNA-dependent RNA polymerase (RdRP) and envelope (E) genes (25).
T116 422-655 Sentence denotes Both assays have high analytic sensitivity and specificity for SARS–CoV-2, with minimal cross-reactivity with other circulating strains of coronaviruses, and both use a cycle threshold of less than 40 as the criterion for positivity.
T117 656-939 Sentence denotes The CDC kit may be used by state public health laboratories, other laboratories determined by the state to be qualified, and clinical laboratories that meet the regulatory requirements of the Clinical Laboratories Improvement Amendment (CLIA) to perform high-complexity testing (27).
T118 940-1074 Sentence denotes Dozens of laboratories have applied for Emergency Use Authorization (EUA) from the FDA for their own laboratory-developed assays (34).
T119 1075-1229 Sentence denotes The FDA also has granted an EUA for several commercial assays (35), further expanding the ability of clinical laboratories to use these platforms (Table).